Dow Jones Sells Off As Moderna CEO Expects Less Effective Vaccines For Omicron
Futures fell sharply Tuesday, as the Moderna CEO predicted existing vaccines will be less effective vs. omicron.
#dowjonessellsoff
Dow Jones Sells Off As Moderna CEO Expects Less Effective Vaccines For Omicron
Upworthy
0 shares
1 views
You might like
Related news coverage
What does the Omicron-related uncertainty mean for investors?
Invezz
The benchmark S&P 500 index is down more than 1.0% this morning on fears the existing COVID-19 vaccines and treatments will be less..
-
RR Donnelley, Lithia Motors rise; Intuit, Moderna fall
SeattlePI.com
-
Existing vaccines might not be effective against omicron variant right away, Moderna CEO says
Washington Post
-
Moderna CEO Says COVID-19 Vaccine Likely Less Effective Against Omicron
Daily Caller
-
Moderna CEO Sounds Alarm on Reduced Vaccine Effectiveness Against Omicron: ‘This Is Not Going to Be Good’
Mediaite
Advertisement
More coverage
Moderna CEO says vaccines likely less effective against Omicron
CTV News
The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus..
-
Covid-19 shots less effective against Omicron, warns Moderna CEO
Indian Express
-
Dow futures drop 450 points after Moderna CEO predicts vaccines will be less effective against Omicron
Business Insider
-
Markets hit by Moderna vaccine warning over Omicron
Bangkok Post
-
Coronavirus digest: Moderna chief warns omicron could dodge vaccines
Deutsche Welle